Cochrane Abstracts
Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Phyllanthus Species Versus Antiviral Drugs for Chronic Hepatitis B Virus Infection." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434990/all/Phyllanthus_species_versus_antiviral_drugs_for_chronic_hepatitis_B_virus_infection.
Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434990/all/Phyllanthus_species_versus_antiviral_drugs_for_chronic_hepatitis_B_virus_infection. Accessed January 13, 2026.
Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434990/all/Phyllanthus_species_versus_antiviral_drugs_for_chronic_hepatitis_B_virus_infection
Phyllanthus Species Versus Antiviral Drugs for Chronic Hepatitis B Virus Infection [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434990/all/Phyllanthus_species_versus_antiviral_drugs_for_chronic_hepatitis_B_virus_infection.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection
ID - 434990
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434990/all/Phyllanthus_species_versus_antiviral_drugs_for_chronic_hepatitis_B_virus_infection
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
